Cargando…

A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery

Oxidized low-density lipoproteins play an important role in tissue pathology. In this study, we report a sensitive novel enzyme-linked immunosorbent assay for the detection of malondialdehyde-modified low-density lipoprotein (MDA-LDL), a key component of oxidized LDL. The assay is capable of measuri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Samata S., Hartley, Adam, Caga-Anan, Mikhail, Ammari, Tareq, Khan, Ameer Hamid Ahmed, Nguyen, Bao Anh Vu, Kojima, Chiari, Anderson, Jon, Lynham, Steven, Johns, Michael, Haskard, Dorian O., Khamis, Ramzi Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389242/ https://www.ncbi.nlm.nih.gov/pubmed/34439546 http://dx.doi.org/10.3390/antiox10081298

Ejemplares similares

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
por: Hartley, Adam, et al.
Publicado: (2022)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021)

Developing a Strategy for Interventional Molecular Imaging of Oxidized Low-Density Lipoprotein in Atherosclerosis
por: Pandey, Samata S., et al.
Publicado: (2017)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021)

High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial()
por: Khamis, Ramzi Y., et al.
Publicado: (2016)

Markers of Apoptosis Predict Cardiovascular Outcomes and Point to ‘Response to Injury’ as a Common Pathway Leading to Diabetes and Cardiovascular Events
por: Hartley, Adam, et al.
Publicado: (2018)

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
por: van den Berg, Victor J., et al.
Publicado: (2018)

Anti-Oxidized LDL Antibodies and Coronary Artery Disease: A Systematic Review
por: van den Berg, Victor J., et al.
Publicado: (2019)

Evaluation of Paraoxonase, Malondialdehyde, and Lipoprotein Levels in Patients with Asymptomatic Cholelithiasis
por: Atamer, Aytac, et al.
Publicado: (2014)

Comparison of plasma lipoprotein profiles and malondialdehyde between hyperlipidemia dogs with/without treatment
por: Li, Gebin, et al.
Publicado: (2014)

Serum Malondialdehyde-Oxidized Low-Density Lipoprotein Level Is Associated with Arterial Stiffness by Cardio-Ankle Vascular Index in Coronary Artery Bypass Graft Patients
por: Hung, Ting, et al.
Publicado: (2023)

Voice Biomarkers: The Most Modern and Least Invasive Tool for Coronary Assessment?
por: Hartley, Adam, et al.
Publicado: (2022)

Recognition of Porphyromonas gingivalis Gingipain Epitopes by Natural IgM Binding to Malondialdehyde Modified Low-Density Lipoprotein
por: Turunen, S. Pauliina, et al.
Publicado: (2012)

Malondialdehyde Level in the Cord Blood
por: Joob, Beuy, et al.
Publicado: (2012)

Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
por: Hou, Jia-Sian, et al.
Publicado: (2020)

Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
por: Teragawa, Hiroki, et al.
Publicado: (2023)

Interfering lipoproteins in magnetic field-assisted agglutination of superparamagnetic particles immunoassay
por: Cauet, Gilles, et al.
Publicado: (2016)

CAMs and Anti-CAMs. The Clinical Potential of Cell Adhesion Molecules
por: Keelan, Edward, et al.
Publicado: (1992)

Structural and Functional Analysis of Sulfolobus solfataricus Y-Family DNA Polymerase Dpo4-Catalyzed Bypass of the Malondialdehyde−Deoxyguanosine Adduct(,)
por: Eoff, Robert L., et al.
Publicado: (2009)

Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response
por: Haskard, Dorian O, et al.
Publicado: (2002)

Behçet’s Syndrome
por: Pickering, Matthew C, et al.
Publicado: (2000)

Levels of Malondialdehyde and Superoxide Dismutase in Subclinical Hyperthyroidism
por: Cetinkaya, Ali, et al.
Publicado: (2005)

Malondialdehyde Level in the Cord Blood of Newborn Infants
por: Gülbayzar, Sayat, et al.
Publicado: (2011)

Author's Reply, Malondialdehyde Level in the Cord Blood
por: Arica, Vefik
Publicado: (2012)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Malondialdehyde can predict survival in hemodialysis patients
por: RUSU, CRINA CLAUDIA, et al.
Publicado: (2016)

Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein
por: Kyrklund, Mikael, et al.
Publicado: (2018)

In Vitro Bypass of the Major Malondialdehyde- and Base Propenal-Derived DNA Adduct by Human Y-family DNA Polymerases κ, ι, and Rev1
por: Maddukuri, Leena, et al.
Publicado: (2010)

Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease
por: Yokoi, Masashi, et al.
Publicado: (2023)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
por: Merendino, Rosaria Alba, et al.
Publicado: (2003)

Levels of superoxide dismutase and malondialdehyde in primary spontaneous pneumothorax.
por: Tabakoglu, Erhan, et al.
Publicado: (2004)

Elevated malondialdehyde levels in sepsis - something to 'stress' about?
por: Weiss, Scott L, et al.
Publicado: (2014)

Response to: Serum Paraoxonase and Malondialdehyde Levels in Asymptomatic Cholelithiasis
por: Atamer, Aytaç, et al.
Publicado: (2016)

Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C
por: Khedr, Mohammed Ahmed, et al.
Publicado: (2019)

Increased serum malondialdehyde concentration in cows with subclinical ketosis
por: SENOH, Taisuke, et al.
Publicado: (2019)

Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma
por: MAJIDI, Ziba, et al.
Publicado: (2017)

Malondialdehyde as a Marker of Oxidative Stress in Periodontitis Patients
por: Cherian, Deepthi A., et al.
Publicado: (2019)

Malondialdehyde-Induced Post-Translational Modification of Human Hemoglobin
por: Tsikas, Dimitrios
Publicado: (2023)

Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer
por: Wyness, Sara P., et al.
Publicado: (2021)

Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy
por: Ichikawa, Keishi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_12u7ulggfvrdj1kuo8366b4olo